Seeking Alpha

Science 37 Wins 2023 MedTech Breakthrough Award for "Best Overall Clinical Trial Platform"

RESEARCH TRIANGLE PARK, N.C., May 18, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (SNCE), the clinical research industry-leading Metasite™, has been named the winner of the prestigious "Best ...
Seeking Alpha

Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards under the ...
Nasdaq

Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment

RESEARCH TRIANGLE PARK, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) (the “Company” or “Science 37”), the clinical research industry’s leading MetasiteTM, today ...
FierceBiotech

Science 37 tapped for Synlogic's phase 3 trial of potential PKU treatment

Science 37 has been tapped to use its virtual clinical trial tech for phase 3 trials of Synlogic’s treatment for the rare genetic metabolic disorder phenylketonuria (PKU). Under the deal, Science 37’s ...
Nasdaq

Science 37® Extends Leadership in Decentralized Clinical Trial Market with NextGen SaaS Release to Fully Orchestrate Decentralized Study Conduct

New release sets the bar as the most comprehensive platform to orchestrate decentralized study conduct—unifying stakeholder journeys, increasing compliance, and generating the highest-quality data for ...
Business Wire

Science 37 and AOBiome Complete Industry-First Virtual Clinical Trial Through Metasite™ (Decentralized) Operating Model

PLAYA VISTA, Calif.--(BUSINESS WIRE)--Science 37, a trailblazing company focused on “site-less” clinical trials, announced today the completion of a Phase 2b study for AOBiome, a clinical-stage life ...
MarketWatch

Science 37 Launches Dedicated Pediatrics Department to Expand Access to Specialized Clinical Research for Children and Families

The MarketWatch News Department was not involved in the creation of this content. MORRISVILLE, N.C., March 17, 2026 (GLOBE NEWSWIRE) -- Science 37, the leader in expanding patient access to clinical ...
Knoxville News Sentinel

Science 37 Becomes First FDA-Inspected Site to Deliver Clinical Trials to Patients’ Homes

Science 37 is a leading patient access company in clinical research that delivers trials directly to patients’ homes. We go directly to the patient’s home, providing a seamless clinical trial ...
MarketWatch

Science 37 Named Finalist in Two Categories for the 2026 SCOPE Awards

The MarketWatch News Department was not involved in the creation of this content. MORRISVILLE, N.C., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Science 37, the leader in expanding patient access to clinical ...
manilatimes

Science 37 Launches Dedicated Pediatrics Department to Expand Access to Specialized Clinical Research for Children and Families

MORRISVILLE, N.C., March 17, 2026 (GLOBE NEWSWIRE)-- Science 37, the leader in expanding patient access to clinical trials, today announced the formal launch of its dedicated Pediatrics Department, ...